Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica
Tetsuya Akaishi(Tohoku University Hospital), Kazuo Fujihara(Tohoku University), Tatsuro Misu(Fukushima Medical University), Toru Nakazawa(Tohoku University), Shuhei Nishiyama(Fukushima Medical University), Toshiyuki Takahashi(Fukushima Medical University), Takayuki Takeshita(Tohoku University), Ichiro Nakashima(Tohoku University), Masashi Aoki(Tohoku University), Douglas Kazutoshi Sato(Fukushima Medical University), Kazuhiro Kurosawa(Tohoku University), Shunji Mugikura(Tohoku University)
Cited by 82
Related Papers
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
|Neurology Neuroimmunology & Neuroinflammation|2017|432
CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
|Journal of Neurology Neurosurgery & Psychiatry|2018|199
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study: Table 1
|Journal of Neurology Neurosurgery & Psychiatry|2015|141
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies
|Journal of Neurology Neurosurgery & Psychiatry|2016|108